GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Zoetis Inc.
Zoetis is a global leader in veterinary medicine. The company produces medications and vaccines for pets and livestock. Its share price growth is fueled by the trend toward humanizing pets and the growing global demand for animal protein.
Share prices of companies in the market segment - Pets
Zoetis, spun off from Pfizer, is the world's largest company focused exclusively on animal health, from livestock vaccines to pet medications. We classify it as part of the Pets sector, and the chart below reflects the overall performance of this segment.
Broad Market Index - GURU.Markets
Zoetis is the world's largest animal health company, producing medicines and vaccines for pets and farm animals. Its leadership makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Zoetis compares to it.
Change in the price of a company, segment, and market as a whole per day
ZTS - Daily change in the company's share price Zoetis Inc.
For Zoetis, a leader in veterinary medicine, daily price changes reflect its stability and response to demand for pet products. While the graph of these fluctuations is unspectacular, it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pets
Zoetis Inc. is a global leader in the veterinary pharmaceuticals market. This chart shows the average daily volatility of the healthcare sector. Comparing this to ZTS's performance helps understand how resilient its business, which relies on spending on pets and farm animals, is to economic cycles.
Daily change in the price of a broad market stock, index - GURU.Markets
Zoetis is a global leader in veterinary medicine, producing medications and vaccines for animals. The pet and livestock market is considered resilient. The chart below shows the overall market volatility, which may make Zoetis appear more secure.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Zoetis Inc.
Zoetis is a global leader in veterinary medicine. Its year-over-year performance reflects stable and growing demand for animal medicines and vaccines, which is largely unaffected by economic cycles. The chart below tells the story of this resilient market.
Annual dynamics of market capitalization of the market segment - Pets
Zoetis Inc. is a global leader in veterinary medicine, from vaccines to pet and livestock medications. The company's growth is fueled by the trend toward humanizing pets and the growing demand for protein. This ensures stable growth, often outperforming both the pharmaceutical and consumer sectors.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zoetis is a global leader in veterinary medicine, from vaccines to pharmaceuticals for pets and livestock. The company's growth is driven by the long-term trend toward the humanization of pets and the growing demand for protein. This makes its business resilient to economic cycles and attractive to investors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Zoetis Inc.
Zoetis, a global leader in veterinary medicine, highlights the growing importance of animal health. The monthly fluctuations on the chart reflect the demand for medications and vaccines for both pets and farm animals, a steadily growing market.
Monthly dynamics of market capitalization of the market segment - Pets
This chart reflects the dynamics of the animal health sector. For Zoetis, a global leader in this field, it provides context. Its steady growth demonstrates how the increasing number of pets and concern for their health are creating a powerful and sustainable trend for the entire industry.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zoetis is a global leader in the production of medicines and vaccines for companion and farm animals. "Humanized" pet medicine is a powerful and stable trend. The chart below shows general market fluctuations. To what extent is the animal health sector independent of these trends?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Zoetis Inc.
The weekly performance of Zoetis, a global leader in veterinary pharmaceuticals, reflects the growing importance of animal health. The stock responds to new product launches, demographic trends in pet ownership, and the state of the agricultural sector, revealing the pulse of this unique and steadily growing industry.
Weekly dynamics of market capitalization of the market segment - Pets
The animal health industry is a steadily growing sector. Its weekly dynamics reflect overall trends in pet spending and the state of the agricultural sector. This chart illustrates this overall positive trend, which underscores Zoetis' leadership and innovation in veterinary medicine.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Zoetis is a global leader in animal medicines and vaccines. Pet spending is considered relatively stable. The chart below will help you determine whether Zoetis shares exhibit defensive properties: do they demonstrate resilience during general market turbulence or do they move with the market?
Market capitalization of the company, segment and market as a whole
ZTS - Market capitalization of the company Zoetis Inc.
Zoetis's market capitalization tells the story of how animal health care has grown into a massive and profitable industry. The chart shows steady growth, fueled by the trend toward humanizing pets and the growth of global livestock farming. This metric's dynamics reflect the market's assessment of the company's leadership in veterinary drugs and vaccines.
ZTS - Share of the company's market capitalization Zoetis Inc. within the market segment - Pets
Zoetis is the undisputed global leader in veterinary medicine and animal health. The company holds a dominant market share thanks to its broad portfolio of vaccines and medications for companion and farm animals. Its sector weighting reflects its scientific excellence and scale in the growing animal care industry.
Market capitalization of the market segment - Pets
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. The chart below shows the total market capitalization of the animal health sector. Its steady growth reflects the global trend toward the humanization of pets and rising health care costs, creating ideal conditions for Zoetis's dominance.
Market capitalization of all companies included in a broad market index - GURU.Markets
Zoetis is a global leader in animal health, from pets to livestock. Its growing market capitalization reflects a powerful trend toward more humane animal care and food security. This unique niche, whose steady growth significantly contributes to the overall global market value.
Book value capitalization of the company, segment and market as a whole
ZTS - Book value capitalization of the company Zoetis Inc.
Zoetis's assets include its research and development laboratories, veterinary drug manufacturing facilities, and patent portfolio. Its book value reflects the tangible capital invested in animal health worldwide. How has this research-intensive foundation developed? The chart below illustrates its growth and investment dynamics.
ZTS - Share of the company's book capitalization Zoetis Inc. within the market segment - Pets
Zoetis focuses on animal health through a global network of manufacturing facilities and research laboratories. The chart shows the share of these specialized tangible assets in the sector, demonstrating the physical scale behind the creation of veterinary drugs.
Market segment balance sheet capitalization - Pets
Pharmaceuticals are an R&D-intensive business, but in the case of Zoetis, they're also capital-intensive. Global production of veterinary drugs and vaccines requires the ownership of large factories and laboratories, making the company a heavyweight relative to the broader healthcare sector.
Book value of all companies included in the broad market index - GURU.Markets
Zoetis's book value reflects its global network of research centers, laboratories, and manufacturing facilities that create animal medicines and vaccines. This metric reflects the physical scale of the company, which protects the health of both pets and livestock. The chart helps assess its importance within the agricultural sector.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Zoetis Inc.
Zoetis, a leader in veterinary medicine, is valued by the market far beyond its laboratories and manufacturing facilities. The award is a testament to its portfolio of patented animal medicines, its scientific prowess, and the growing global attachment people have to their pets. The chart illustrates this belief in animal health.
Market to book capitalization ratio in a market segment - Pets
Zoetis is a global leader in animal medicines. Its value lies in its patent portfolio and scientific research. This chart shows that the market values the company far above the value of its laboratories and factories, factoring in the potential for future veterinary blockbusters.
Market to book capitalization ratio for the market as a whole
Zoetis is a global leader in veterinary medicine, from vaccines to animal health products. The company boasts a strong patent portfolio and a renowned brand, which are its core assets. This metric demonstrates the market's high valuation of the growing and non-cyclical pet care sector, which is valued significantly above its book value.
Debts of the company, segment and market as a whole
ZTS - Company debts Zoetis Inc.
Zoetis, a global leader in veterinary medicine, uses debt to finance its growth, which includes both organic development and strategic acquisitions. This leverage allows the company to invest in R&D and acquire promising biotech startups. This chart shows how the company is expanding its market dominance.
Market segment debts - Pets
Zoetis is a global leader in animal medicines and vaccines. This is a fast-growing and stable market. The company's debt can be used to fund research, develop new drugs, or acquire other veterinary companies. This chart provides an overview of Zoetis's financial strategy and its appetite for leveraged expansion.
Market debt in general
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. This is a fast-growing and relatively stable market. The company uses capital for research and acquisitions. The chart below helps assess how prudently Zoetis manages its debt to fund growth compared to other industries, and how this impacts its financial stability.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Zoetis Inc.
Zoetis, a global leader in animal health, uses debt to fund research, development, and strategic acquisitions. This chart shows how much the company relies on debt for growth. It allows investors to assess how leverage affects profitability and the risks of debt in a stable sector.
Market segment debt to market segment book capitalization - Pets
Zoetis, a global leader in veterinary medicine and pharmaceuticals, invests heavily in the research and development of new animal health products. This chart compares the company's debt to the total book value of the entire pet products sector. It helps understand how Zoetis uses debt to strengthen its market position and fund innovation.
Debt to book value of all companies in the market
Zoetis, a global leader in veterinary medicine, operates in a market considered resilient to economic downturns. This chart compares the company's debt to the total capitalization of the entire stock market. It allows us to assess whether the company's financial policies are truly less cyclical and more predictable than the market as a whole.
P/E of the company, segment and market as a whole
P/E - Zoetis Inc.
Zoetis is a global leader in veterinary pharmaceuticals and vaccines for pets and livestock. This chart shows how investors value the growing and resilient pet care market. The high valuation reflects the long-term trend toward the humanization of pets and, consequently, rising health care costs.
P/E of the market segment - Pets
Zoetis is a global leader in animal health, developing and manufacturing medicines and vaccines for companion and farm animals. This sector is fast-growing and stable. This chart shows the average rating for pet-related companies and helps understand how highly the market values Zoetis' leadership and innovation.
P/E of the market as a whole
Zoetis is a global leader in veterinary medicine and animal health. This market demonstrates stable growth, largely unaffected by economic cycles. Does comparing Zoetis's valuation to this broader market benchmark suggest it is a safe haven? Or are investors viewing it like any other growth company subject to overall sentiment?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Zoetis Inc.
Zoetis is a global leader in veterinary medicine, producing medications and vaccines for animals. The company's future profits are fueled by the persistent trend toward the humanization of pets and rising demand for protein. This chart reflects market expectations for continued growth in animal health spending worldwide.
%20P%2FE%20Zoetis%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Zoetis-Inc.&v=1772630514885 "Chart of the company's future (projected) P/E Zoetis Inc.")
Future (projected) P/E of the market segment - Pets
Zoetis is a global leader in animal health, developing and manufacturing medications and vaccines for companion and farm animals. This chart shows how the market views Zoetis's profitability prospects relative to the overall sector. It reflects analysts' confidence in the stable growth of the pet care market and the company's dominant position.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pets&v=1772630514889 "Future (projected) P/E graph of the market segment - Pets")
Future (projected) P/E of the market as a whole
Zoetis is a global leader in animal medicines and vaccines. Their business is growing thanks to the trend toward making pets more humane. This market expectations chart helps assess how much investors are willing to pay for stable and predictable growth in a sector that is less dependent on economic cycles than many others.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772630514902 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Zoetis Inc.
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. This chart shows how the company is capitalizing on growing public concern for pet health and farm animal productivity. Its robust profit growth reflects continued demand for its innovative products in the non-cyclical sector.
Profit of companies in the market segment - Pets
Zoetis is a global leader in veterinary pharmaceuticals and vaccines for companion and farm animals. This chart shows the profitability trend in the pet care sector. The company's growth is driven by the trend toward humanizing pets and the growing demand for protein, which ensures the stable development of this unique industry.
Overall market profit
Zoetis is a global leader in animal medicines and vaccines. Its business is unique in that pet care is often the last item owners save. However, the overall economic situation, reflected in the graph, is impacting the livestock sector. Rising farm profits allow them to invest more in livestock health.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Zoetis Inc.
Zoetis is a global leader in veterinary medicine, producing animal medicines and vaccines. This chart shows analysts' expectations for future revenue, driven by the global trend toward the humanization of pets and the growing demand for animal protein, which necessitates healthy livestock.
%20profit%20of%20the%20company%20Zoetis%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Zoetis-Inc.&v=1772630515093 "Graph of future (projected) profit of the company Zoetis Inc.")
Future (predicted) profit of companies in the market segment - Pets
Zoetis is a global leader in veterinary medicine, developing medicines and vaccines for companion and farm animals. This chart shows profitability forecasts for the pet industry. It reflects the global trend toward humanizing pets and growing concern for their health, providing context for assessing the prospects of this leader in this unique market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pets&v=1772630515113 "Graph of future (predicted) profits of companies in a market segment - Pets")
Future (predicted) profit of the market as a whole
Zoetis is a global leader in the production of medicines and vaccines for pets and farm animals. Pet spending remains resilient even in challenging times, but it still depends on disposable income. The positive economic outlook, reflected in this chart, indicates a greater willingness to spend on the health of their pets.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772630515115 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Zoetis Inc.
Zoetis is a global leader in veterinary pharmaceuticals and vaccines for animals. This chart shows the premium the market pays for the company's revenue. This high valuation reflects the robust growth of the pet care and livestock market, which is less susceptible to economic cycles than many other industries.
P/S market segment - Pets
Zoetis is a global leader in veterinary medicine, developing and manufacturing medications and vaccines for pets and livestock. It's a steadily growing business driven by the trend toward "humanization" of pets. This chart shows the average valuation in the sector, helping to understand the premium investors are paying for Zoetis's dominant position in this unique market.
P/S of the market as a whole
Zoetis is a global leader in veterinary medicine, producing medications and vaccines for livestock and companion animals. The company's growth is fueled by the global trend toward pet care. This chart helps understand how the market values the revenue of this steadily growing and niche company compared to the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Zoetis Inc.
Zoetis is a global leader in animal health, developing medicines and vaccines for pets and livestock. This chart reflects investors' high expectations for the company's future earnings. It demonstrates the market's confidence in sustainable growth, driven by the trend toward more humanized pets and the global need for food.
%20P%2FS%20Zoetis%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Zoetis-Inc.&v=1772630515166 "The graph of the company's future (projected) P/S Zoetis Inc.")
Future (projected) P/S of the market segment - Pets
Zoetis is a global leader in animal health, producing medications and vaccines for livestock and companion animals. This chart compares Zoetis's market valuation of future sales with that of its sector peers. It reflects investor confidence in the long-term trend toward more humane pets and the growing demand for high-quality animal health products.
%20P%2FS%20market%20segment%20graph%20-%20Pets&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pets&v=1772630515179 "Future (projected) P/S market segment graph - Pets")
Future (projected) P/S of the market as a whole
Zoetis is a global leader in veterinary medicines and vaccines for animals. Pet spending demonstrates remarkable resilience to economic downturns. While this chart reflects general market expectations, Zoetis's business is supported by a long-term trend toward the humanization of pets, making it less dependent on general economic cycles.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772630515187 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Zoetis Inc.
This chart visualizes the revenue of Zoetis, a global leader in animal health. The company's revenue comes from sales of medications, vaccines, and diagnostic products for farm animals and pets. This growth reflects the global trend toward increased protein consumption, as well as growing concern for the health of their pets, making the business sustainable.
Sales of companies in the market segment - Pets
Zoetis is a global leader in veterinary pharmaceuticals and vaccines for animals. The company is benefiting from the global trend toward humanizing pets and the growing livestock population. This chart shows total revenue in the pet products segment. It reflects the growing global spending on pet health and well-being, a key driver of Zoetis's long-term growth.
Overall market sales
Zoetis is a global leader in the production of medicines and vaccines for livestock and companion animals. Rising global affluence, which is indirectly reflected in this revenue chart, directly impacts the company's business. People are spending more on their pets' health, driving demand for Zoetis' innovative products and services worldwide.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Zoetis Inc.
Zoetis is a global leader in veterinary medicine, developing medications and vaccines for animals. This sales forecast chart reflects the ongoing trend toward humane pet ownership and growing demand for protein. The revenue increase suggests expectations for rising health costs for both pets and farm animals.
%20sales%20of%20the%20company%20Zoetis%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Zoetis-Inc.&v=1772630515266 "Schedule of future (projected) sales of the company Zoetis Inc.")
Future (projected) sales of companies in the market segment - Pets
Zoetis is a global leader in animal health. The company develops and manufactures medications, vaccines, and diagnostics for pets and livestock, focusing on their health. This chart shows revenue expectations for the entire pet care segment, reflecting the growing trend toward humane treatment of pets and higher standards in animal husbandry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pets&v=1772630515282 "Schedule of future (projected) sales of companies in the market segment - Pets")
Future (projected) sales of the market as a whole
Zoetis is a global leader in veterinary medicine and vaccines for animals. Economic growth and consumer spending, as projected in this chart, positively impact the company's business. Increasing household income often leads to increased spending on pet health and well-being, directly supporting demand for Zoetis products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772630515303 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Zoetis Inc.
Zoetis is a global leader in veterinary pharmaceuticals and animal vaccines. This chart demonstrates the high profitability of its research- and innovation-driven business. The company successfully monetizes its patented products for companion and farm animals, ensuring consistently high efficacy and pricing power.
Market segment marginality - Pets
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. The company's success depends on the profitability of its products for both pets and livestock. This chart shows the average profitability in the sector. It helps assess the strength of Zoetis's product portfolio and its ability to innovate compared to industry trends.
Market marginality as a whole
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. This overall business profitability profile has an indirect impact on the company. When the economy is stable, pet owners and farmers are more likely to spend money on animal health. This ensures stable demand for Zoetis and allows it to invest in the development of new products, strengthening its market position.
Employees in the company, segment and market as a whole
Number of employees in the company Zoetis Inc.
Zoetis is a global leader in animal health. Developing and marketing vaccines and medications for pets and farm animals requires unique expertise. This chart reflects the scale of its team of scientists, veterinarians, and sales representatives working to improve the quality of life and productivity of animals worldwide.
Share of the company's employees Zoetis Inc. within the market segment - Pets
Zoetis is a global leader in animal health. The development, production, and sales of animal medicines and vaccines requires a large and highly specialized workforce of scientists, veterinarians, and sales representatives. This metric underscores Zoetis's dominant position, measuring its share of total employment in the niche yet critical animal health industry.
Number of employees in the market segment - Pets
Zoetis is a global leader in veterinary medicine, developing medications and vaccines for animals. Employment growth in this sector is driven by the global trend toward "humanization" of pets and the growing demand for protein. This chart illustrates how rising spending on animal health has transformed this niche into a large, research-intensive industry.
Number of employees in the market as a whole
Zoetis is a global leader in animal health. The growth of its staff engaged in veterinary drug research and sales reflects the powerful trend toward the humanization of pets and the resilience of this unique economic segment, which is increasingly creating jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Zoetis Inc. (ZTS)
Zoetis is a global leader in veterinary medicines and vaccines. Their value is based on scientific developments, patents, and a strong brand. This chart reflects a business built on intellectual property. Every scientist and employee contributes to the creation of unique products, which drives a high market value per employee.
%20of%20the%20company%20Zoetis%20Inc.%20(ZTS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Zoetis-Inc.-ZTS&v=1772630515493 "Chart of market capitalization per employee (in thousands of dollars) of the company Zoetis Inc. (ZTS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pets
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. It's essentially "Pharma for Animals." Its business model is based on R&D, patents, and a strong brand. This metric compares Zoetis's market valuation per employee to the industry average. A high value indicates that the market highly values the company's intellectual property (its drug portfolio) per researcher or salesperson.
%20by%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pets&v=1772630515498 "Market capitalization per employee (in thousands of dollars) by market segment - Pets")
Market capitalization per employee (in thousands of dollars) for the overall market
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. This metric reflects a research-intensive business model similar to human pharmaceuticals. The company's value lies in its patent portfolio and research. High product margins mean that every employee, from scientists to salespeople, generates significant market value.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772630515515 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Zoetis Inc. (ZTS)
Zoetis is a global leader in animal health. They develop and manufacture vaccines and medications for livestock and pets. This business is similar to human pharmaceuticals: it requires R&D and has high margins. This chart shows how productive their R&D investments are and how efficient their manufacturing and marketing are.
%20Chart%20Zoetis%20Inc.%20(ZTS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Zoetis-Inc.-ZTS&v=1772630515523 "Company Profit Per Employee (in thousands of dollars) Chart Zoetis Inc. (ZTS)")
Profit per employee (in thousands of dollars) in the market segment - Pets
Zoetis is a global leader in veterinary medicine (animal pharmaceuticals). This chart shows the benchmark for the Pets sector. Average profit per employee here is high and stable. This sector is similar to human pharmaceuticals, but with less regulatory pressure and longer product life cycles, which sets a high benchmark for profitability.
%20in%20the%20market%20segment%20-%20Pets&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pets&v=1772630515547 "Chart of profit per employee (in thousands of dollars) in the market segment - Pets")
Profit per employee (in thousands of dollars) for the market as a whole
Zoetis is a global leader in veterinary medicines and vaccines. The company's business is driven by research and development, where scientists and researchers play a key role. This chart illustrates the financial return on intellectual capital in the highly specialized and science-intensive pharmaceutical industry.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772630515564 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Zoetis Inc. (ZTS)
Zoetis is a global leader in veterinary pharmaceuticals and vaccines. This chart demonstrates the profitability and demand of this market. Its high revenue per employee reflects the value of the company's intellectual property, the strength of its brands, and its ability to monetize animal health innovations.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Zoetis-Inc.-ZTS&v=1772630515581 "Sales chart per company employee Zoetis Inc. (ZTS)")
Sales per employee in the market segment - Pets
Zoetis is a global leader in veterinary pharmaceuticals and animal vaccines. Their business is similar to human pharmaceuticals, with high R&D costs and complex manufacturing. This chart shows the average revenue per employee in the segment. It allows us to assess how productive Zoetis's scientific and commercial teams are compared to the industry standard.
Sales per employee for the market as a whole
Zoetis is a global leader in animal health. It's essentially a pharmaceutical company, but for pets and livestock. Their business is built on the research, development, and sale of vaccines and medications. This metric reflects the high margins of their R&D: their team of scientists creates patented drugs that then generate a stable income without requiring a huge production staff.
Short shares by company, segment and market as a whole
Shares shorted by company Zoetis Inc. (ZTS)
Zoetis dominates the market for veterinary drugs and vaccines for pets and livestock. This chart reflects bearish sentiment. Bearish sentiment often points to the stock's very high valuation or fears that even the "perennial" pet care sector will slow due to the economic downturn.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Zoetis-Inc.-ZTS&v=1772630515685 "Short Shares Chart for the Company Zoetis Inc. (ZTS)")
Shares shorted by market segment - Pets
Zoetis is a global leader in veterinary medicine. They produce vaccines and medications for farm animals and pets. This business has benefited from the trend toward humanizing pets. This chart shows the volume of bets against the company. Short positions on Zoetis may increase if investors believe the pet boom is slowing or that owners are cutting back on pet care due to inflation.
Shares shorted by the overall market
Zoetis is a global leader in veterinary medicine, from vaccines to animal diagnostics. This business is considered defensive, as owners spend on pets during any crisis (the "humanization effect"). However, this indicator reflects the overall level of panic. When fear is pervasive, even "safe" growth stocks like ZTS can be subject to sell-offs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Zoetis Inc. (ZTS)
Zoetis is a global leader in veterinary drugs and vaccines. It's in the "animal healthcare" sector, a steadily growing sector. This oscillator helps assess the strength of a trend. A successful launch of a new blockbuster (pet medication) or a strong report proving that people are spending on animals even during a crisis could trigger a rally, pushing the indicator toward the 70 zone.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Zoetis-Inc.-ZTS&v=1772630515737 "RSI 14 indicator chart for the company's stock Zoetis Inc. (ZTS)")
RSI 14 Market Segment - Pets
Zoetis is a global leader in veterinary medicine, producing medications and vaccines for pets and livestock. The RSI_14_Seg for the Pets segment is a temperature indicator for the ever-present industry. It helps us understand whether Zoetis' growth is driven by scientific breakthroughs or whether the entire sector is overheated by the trend toward humanizing pets.
RSI 14 for the overall market
Zoetis (ZTS) is a global leader in veterinary medicine. It's the "Pfizer" for animals. They make medications and vaccines for livestock and pets. This market "temperature" chart has little impact on their business. The trend toward "humanizing" pets is long-term. People will treat their dogs in both euphoria and panic.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ZTS (Zoetis Inc.)
This chart reflects the Wall Street consensus forecast for Zoetis. The target price for this leader in animal health depends on the trend toward "humanization" of pets—owners' willingness to spend money on their treatments as if they were family members. Analysts model demand for blockbuster medications (like Apoquel for allergies) and the health of the livestock sector.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ZTS-Zoetis-Inc.&v=1772630515787 "A chart showing analyst consensus forecasts for the expected stock price. ZTS (Zoetis Inc.)")
The difference between the consensus estimate and the actual stock price ZTS (Zoetis Inc.)
Zoetis (ZTS) is a global leader in animal health, producing vaccines and medications for livestock and pets. This chart shows the perpetual trend estimate. It measures the gap between the price and the consensus target, reflecting the growth potential analysts see from rising pet spending and food security needs.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ZTS-Zoetis-Inc.&v=1772630515796 "A chart showing the difference between the consensus forecast and the actual stock price. ZTS (Zoetis Inc.)")
Analyst consensus forecast for stock prices by market segment - Pets
Zoetis is a global leader in veterinary medicine (animal medications and vaccines). The company is benefiting from the trend toward "humanizing" pets. This chart shows analysts' overall expectations for the entire animal health sector. It reflects whether experts believe people will continue to spend on pets or anticipate savings.
Analysts' consensus forecast for the overall market share price
Zoetis is a global leader in animal health, producing medications and vaccines for livestock and pets. This business is unique. Market sentiment, as shown in this chart, impacts it differently: the livestock segment is dependent on the economy, while spending on pets (the petcare segment) often rises even during a recession.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Zoetis Inc.
Zoetis is a global leader in veterinary medicine. The company produces a wide range of vaccines, medications, and diagnostic equipment for both companion animals (dogs and cats) and livestock. This chart reflects a strong and consistent trend toward humanization of pets. Owners are increasingly willing to spend more on their pets' health, which is driving Zoetis's steady growth.
AKIMA Market Segment Index - Pets
Zoetis is a global leader in veterinary medicine, producing vaccines and medications for farm animals and pets. This comprehensive index evaluates companies. The chart shows the average value for the sector. This benchmark: how does Zoetis's dominance in the perennial pet care market differentiate it from the average competitor?
The AKIM Index for the overall market
Zoetis is a global leader in veterinary medicine. The company produces vaccines and medications for farm animals and, more importantly, for pets. This humane approach to animals is its driving force. This chart, reflecting the market average, is the backdrop. It helps assess how Zoetis, whose business is considered protective (people don't skimp on pets), compares to the overall macroeconomic situation that impacts consumers.
